Edwards Lifesciences Corp shares are up 7.4% after Abbott Laboratories demonstrated its MitraClip heart failure treatment was superior to medical therapy; NOTE: Edwards is developing a heart failure treatment with its GeoForm heart valve.
Benzinga_Newsdesk